What are the Messenger Sports Awards? We thought it would be fun to highlight some of the athletes who stood out to us in ...

Roche Holding (ROCH:CA) now has a Canadian dollar hedged Canadian Depositary Receipt, but it currently lacks liquidity. Read ...

After two seasons with Boston in the National League and ready to take on a bigger role at catcher, Billy Sullivan joined the exodus of players moving from the Senior Circuit to Junior by signing with ...

Roche Holding said it would pay Danish biotechnology research company Zealand Pharma up to $5.3 billion under an agreement to ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor agonists but without the side effects associated with GLP-1 drugs.

Profits and losses for petrelintide and the petrelintide/CT-388 combination will be shared on a 50:50 basis in the U.S. and Europe, while Zealand will be eligible to receive tiered double-digit ...

Neskovic 3-8 2-2 8, Walz 6-10 4-4 16, Artis White 6-10 0-0 17, Roche 0-2 0-0 0, Tyne 3-10 0-0 8, Tanner 3-6 2-3 9, D'Entremont 1-2 0-0 3, Hunt 0-3 0-0 0, Beagle 1-2 2-2 4. Totals 23-53 10-11 65.

Roche has entered an exclusive collaboration and licensing agreement with Zealand Pharma under which the parties will ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Zealand Pharma’s obesity drug candidate.

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

Zealand Pharma shares rose sharply after the Danish pharmaceutical company struck a licensing and collaboration deal of up to $5.3 billion with Roche. Shares in Zealand were up 25% at 609 Danish ...